SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

JERRY (JYAI) is a Matt Furie's artistic style; it features an AI-powered content creation hub that produces community-driven video series and art.  Jerry the Turtle, created by Matt Furie, is a character inspired by Furie’s artistic style. JERRY is also an AI-driven meme coin with an ambitious vision. The goal is to establish an AI-powered production house dedicated to creating a video series or episodes featuring characters from Matt Furie’s universe alongside those from Jerry’s world.  This unique blend of characters aims to produce the ultimate crypto-based series. Additionally, we are developing an app that will offer an exclusive, ad-free video series featuring characters from both Matt Furie’s creations and the Jerry Universe. Users will be able to download and share videos directly through the platform.  But that’s not all! A special Jerry Art Panel will showcase original Jerry characters, artwork, and fan creations—free to explore, download, and share with the community.

Jerry The Turtle By Matt Furie

JYAI CRYPTO is surging amid new exchange listings and an anticipated podcast launch, with its "AI memecoin" narrative fueling community buzz. Investors are actively discussing its "next Pepe" potential, especially with multiple Tier 1 exchange listings reportedly in the pipeline.

For too long, investing has come with barriers. Borders. Brokers. Limitations. It’s been complicated, costly, and — for millions — out of reach. xStocks were created to change that.  xStocks are tokenized stocks. They’re backed 1:1 by the underlying assets, composable with DeFi protocols, compliant with EU regulations, accessible to non-US users, and provide a legal claim to the value of the stock.  xStocks enable easy access to 57 US Stocks and ETFs to regular users through top centralized and decentralized exchanges, and can be integrated with other DeFi protocols like any other token.

Apple xStock

AAPLX CRYPTO is trending as community buzz surrounds the upcoming Jerryverse Podcast submission to Apple Podcasts, signaling new content and increased visibility for the crypto asset.

Rydex Investments - Invesco CurrencyShares Euro Trust

Invesco CurrencyShares Euro Trust

FXE is trending as the euro faces pressure against a strengthening US dollar, driven by the Federal Reserve's firm stance on inflation and robust US economic data, which contrasts with the European Central Bank's more stable policy. The community is actively discussing this central bank divergence and monitoring upcoming inflation reports for clues on currency direction.

TOSHI

TOSHI, known as the "Face of Base" and "blue cat," is trending as its community expresses strong conviction that the crypto is drastically oversold and has bottomed out. Traders are actively accumulating, anticipating a significant rebound and rally in conjunction with improving broader crypto market sentiment and a potential altcoin season.

English version Introducing SWFTCoin (SWFTC) $SWFTC: Powering SWFT Blockchain and AI Services (SWFTGPT)  SwftCoin ($SWFTC) is the native utility token driving SWFT Blockchain's AI-powered ecosystem, SWFTGPT, and the first ever AI token featured on Coinbase. SWFTGPT is also the first domain-specific LLM for crypto.  SwftCoin key features include: 50% Reduced Transaction Fees: Lower costs on all transactions. AI Service Payments: Use $SWFTC to access SWFTGPT. Tools include expert market analysis,  predictions, and intelligent trading solutions.  Membership Benefits: Unlock premium features and AI agent services within SWFTGPT. AI-Powered Swaps: Enable precise, fast cross-chain transactions and analytics. SWFT Blockchain combines AI innovation with blockchain infrastructure, simplifying crypto trading while enhancing functionality through $SWFTC.   Chinese version $SWFTC：驱动 SWFT Blockchain 和 AI 服务（SWFTGPT） SwftCoin ($SWFTC) 是 SWFT Blockchain 的原生实用代币，为其 AI 驱动的生态系统 SWFTGPT 提供支持，同时也是 Coinbase 上首个 AI 代币。SWFTGPT 也是首个专注于加密领域的特定领域大型语言模型 (LLM)。 SwftCoin 的主要功能包括： 1、50% 交易费减免：降低所有交易成本。 2、AI 服务支付：使用 $SWFTC 访问 SWFTGPT 工具，包括专家市场分析、预测以及智能交易解决方案。 3、会员权益：解锁 SWFTGPT 的高级功能和 AI 代理服务。 4、AI 驱动的闪兑：实现精准快速的跨链交易和数据分析。 SWFT Blockchain 将 AI 创新与区块链基础设施结合，通过 $SWFTC 简化加密交易，并提升其功能性。

SwftCoin

SwftCoin is currently trending as community members recall its historical price surges around past Super Bowl events, fueling speculation for a repeat performance. Despite concerns about developer communication, bullish investors are highlighting its fixed supply and cross-chain AI utility, looking for a significant breakout.

ARK Investment Management LLC - ARK Innovation ETF

ARK Innovation ETF

The ARK Innovation ETF is trending as investors critically assess Cathie Wood's latest portfolio moves, which include buying dips in crypto-linked and AI stocks while continuing to trim Tesla, intensifying community debate over the fund's underperformance and the future of speculative growth.

Yearn Finance is a suite of products in Decentralized Finance (DeFi) that provides lending aggregation, yield generation, and insurance on the Ethereum blockchain. The protocol is maintained by various independent developers and is governed by YFI holders.  It started out as a passion project by Andre Cronje to automate the process of switching capital between lending platforms in search of the best yield offered, as the lending yield is a floating rate rather than fixed rate. Funds are shifted between dYdX, AAVE, and Compound automatically as interest rates change between these protocols.   The service offered includes major USD tokens such as DAI, USDT, USDC, and TUSD. For example, if a user deposits DAI into yearn.finance, the user will receive yDAI token in return, which is a yield-bearing DAI token.   Later on, it collaborated with Curve Finance to release a yield-bearing USD tokens pool that includes four y-tokens: yDAI, yUSDT, yUSDC and yTUSD, it is named as yUSD.   Yearn Finance debuted the vault feature after its token launch, igniting a frenzy on automated yield farming and is considered the initiator of the category of yield farming aggregator. Basically, the vault will help users to claim yield farming rewards and sell it for the underlying assets.   Vaults benefit users by socializing gas costs, automating the yield generation and rebalancing process, and automatically shifting capital as opportunities arise. End users also do not need to have proficient knowledge of the underlying protocols involved or DeFi, thus the Vaults represent a passive-investing strategy. It is akin to a crypto hedge fund where the aim is to increase the amount of assets that users deposited.

yearn.finance

The extremely low circulating supply of yearn.finance ($YFI) is fueling community speculation that it is a severely undervalued DeFi asset poised for a significant rally as interest rates decline. Discussion centers on its potential to re-challenge historical highs and show independent growth from Bitcoin, with some also highlighting its strong developer activity within the ecosystem.

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Kodiak Sciences Inc

Kodiak Sciences is trending as community enthusiasm builds around strong Phase 1b data for KSI-101 in inflammatory retinal diseases and the imminent Phase 3 GLOW2 readout, alongside a recently de-risked financial position that fuels confidence in its advancing late-stage pipeline. Investors are actively discussing the potential for blockbuster sales and the company's strategic progress in developing long-acting therapies for the multi-billion dollar retinal market.

Root, Inc. is a technology insurance company, which engages in the provision of insurance services. It offers mobile telematics and technology platforms to segment individual risk based on complex behavioral data and customer experience to make pricing decisions and grow businesses. It provides insurance products and services in the United States. The company was founded by Alexander E. Timm and Daniel Manges in February 2015 and is headquartered in Columbus, OH.

Root Inc - Ordinary Shares - Class A

Root Inc

Root Inc. is generating buzz due to its recent partnership with Kikoff and speculation surrounding a significant white-label insurance deal with Hyundai, intensifying the debate between bullish investors and vocal skeptics. Many in the community believe the stock is fundamentally undervalued, with current price dips attributed to concerted short-seller activity ahead of anticipated strong Q4 results and robust Q1 seasonal growth, while others question management's effectiveness against established rivals.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - VR PRF PERPETUAL USD 100 - Ser A

Strategy Inc Variable Rate Series A Perpetual Stretch Preferred

Strategy Inc. Variable Rate Series A Perpetual Stretch Preferred (STRC) is trending due to its consistently high variable dividend yield, recently increased to 11.25%, and its notable resilience in maintaining its $100 par value. The community is captivated by its appeal as a monthly income investment and its crucial role in funding Strategy's ongoing Bitcoin acquisitions, although some express skepticism regarding its underlying model.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

United Therapeutics Corporation $UTHR Shares Sold by Ashton Thomas Private Wealth LLC

Ashton Thomas Private Wealth LLC cut its holdings in shares of United Therapeutics Corporation (NASDAQ:UTHR - Free Report) by 79.7% during the third quarter, according to the company in its most...

Allianz Asset Management GmbH Trims Stake in United Therapeutics Corporation $UTHR

Allianz Asset Management GmbH lowered its position in United Therapeutics Corporation (NASDAQ:UTHR - Free Report) by 29.7% in the 3rd quarter, according to the company in its most recent disclosure...

Merck's Subdued 2026 Outlook: What it Means After Q4 Results?

MRK posts conservative 2026 sales and EPS outlook, given acquisition charges. Keytruda, Animal Health and new drug launches are expected to drive 2026 growth.

United Therapeutics (NASDAQ:UTHR) EVP Paul Mahon Sells 8,300 Shares

United Therapeutics Corporation (NASDAQ:UTHR - Get Free Report) EVP Paul Mahon sold 8,300 shares of the firm's stock in a transaction that occurred on Thursday, February 5th. The shares were sold at...

BI Asset Management Fondsmaeglerselskab A S Cuts Stock Holdings in United Therapeutics Corporation $UTHR

BI Asset Management Fondsmaeglerselskab A S lessened its stake in United Therapeutics Corporation (NASDAQ:UTHR - Free Report) by 28.4% during the third quarter, according to the company in its most...

Paul Mahon Sells 8,300 Shares of United Therapeutics (NASDAQ:UTHR) Stock

United Therapeutics Corporation (NASDAQ:UTHR - Get Free Report) EVP Paul Mahon sold 8,300 shares of United Therapeutics stock in a transaction dated Thursday, February 5th. The shares were sold at an...

Biotech Stocks To Add to Your Watchlist - February 5th

Danaher, argenex, Vertex Pharmaceuticals, Moderna, Recursion Pharmaceuticals, United Therapeutics, and Medpace are the seven Biotech stocks to watch today, according to MarketBeat's stock screener...

Principal Financial Group Inc. Sells 5,583 Shares of United Therapeutics Corporation $UTHR

Principal Financial Group Inc. decreased its stake in shares of United Therapeutics Corporation (NASDAQ:UTHR - Free Report) by 5.0% during the third quarter, according to the company in its most...

United Therapeutics (NASDAQ:UTHR) Director Jan Malcolm Sells 50 Shares

United Therapeutics Corporation (NASDAQ:UTHR - Get Free Report) Director Jan Malcolm sold 50 shares of the stock in a transaction that occurred on Tuesday, February 3rd. The stock was sold at an...

Mediolanum International Funds Ltd Sells 4,275 Shares of United Therapeutics Corporation $UTHR

Mediolanum International Funds Ltd cut its holdings in shares of United Therapeutics Corporation (NASDAQ:UTHR - Free Report) by 23.2% in the third quarter, according to the company in its most recent...

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

United Therapeutics Corp

Up 5%

Down 5%

Markets are hovering near key levels, making the next 5% move especially important for sentiment. A breakout higher could reinforce the bull case, while a 5% drop may signal rising risk and tighter conditions. Which comes first?

What will be the S&amp;P 500’s next 5% move?

Stocktwits

What will be the S&P 500’s next 5% move?

Current Price	$486.86
Prev Close	$478.93
Open	$483.81
Dividend Yield	0.00%
50-Day Moving Average	$486.64
Beta	0.43
Avg. Volume	353,460.35
PE Ratio	18.40

52-Week High	$519.99
52-Week Low	$266.98
Market Capitalization	$33.82B
EPS (Annual)	$24.64
Price to Book	3.16
Revenue Per Employee	$2.2M
Enterprise Value/EBITDA	N/A

UTHR
United Therapeutics Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest UTHR News

UTHRUnited Therapeutics Corp